2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4371):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W048402
    Neratinib impurity 11
    Neratinib impurity 11 is an impurity of Neratinib (HY-32721).
    Neratinib impurity 11
  • HY-Z6535
    Lidocaine impurity 12
    		99.54%
    Lidocaine impurity 12 is an impurity of Lidocaine (HY-B0185).
    Lidocaine impurity 12
  • HY-W011048
    2,2-Bis(3-phenyl-4-hydroxyphenyl)propane
    2,2-Bis(3-phenyl-4-hydroxyphenyl)propane (BisOPP-A) is a bioactive chemical, and can be used for the synthesis of active compound.
    2,2-Bis(3-phenyl-4-hydroxyphenyl)propane
  • HY-W021132
    7-Chloro-6-nitroquinoline
    7-Chloro-6-nitroquinoline is a drug intermediate for synthesis of various active compounds.
    7-Chloro-6-nitroquinoline
  • HY-75398
    1-(5-Chloro-2-phenoxyphenyl)ethanone
    		99.81%
    1-(5-Chloro-2-phenoxyphenyl)ethanone is a drug intermediate for synthesis of various active compounds.
    1-(5-Chloro-2-phenoxyphenyl)ethanone
  • HY-136476G
    Pt(II) protoporphyrin IX
    Pt(II) protoporphyrin IX is a protoporphyrin IX. Protoporphyrin IX is a heterocyclic organic compound, which consists of four pyrrole rings, and is the final intermediate in the heme biosynthetic pathway.
    Pt(II) protoporphyrin IX
  • HY-114296
    2,3-Oxidosqualene
    		99.9%
    2,3-Oxidosqualene (Squalene oxide) is a sterol biosynthesis precursor intermediate.2,3-Oxidosqualene participates in cyclization pathways that form sterols and triterpenes, and contributes to introduction of their characteristic 3-hydroxyl group.2,3-Oxidosqualene forms metabolically from squalene in rat liver homogenates under sterol synthesis conditions.2,3-Oxidosqualene converts to sterols including cholesterol, lathosterol, and lanost-8-en-3β-ol in rat liver homogenates under anaerobic conditions.
    2,3-Oxidosqualene
  • HY-W004879
    Dimethyl pyridine-2,5-dicarboxylate
    		99.78%
    Dimethyl pyridine-2,5-dicarboxylate is a chemical intermediate. Dimethyl pyridine-2,5-dicarboxylate can be used to synthesize Compound 5. Compound 5 has three conventional hydrogen bonds with SER293, SER251, and SER252.
    Dimethyl pyridine-2,5-dicarboxylate
  • HY-W794132
    4-Hydroxy-9h-xanthen-9-one
    		98.0%
    4-Hydroxy-9h-xanthen-9-one is a natural product.
    4-Hydroxy-9h-xanthen-9-one
  • HY-42895
    (3R)-4-(4-Fluorobenzoyl)-3-methyl-2-piperazinone
    (3R)-4-(4-Fluorobenzoyl)-3-methyl-2-piperazinone is a drug intermediate for synthesis of various active compounds.
    (3R)-4-(4-Fluorobenzoyl)-3-methyl-2-piperazinone
  • HY-W144281
    N'-Hydroxy-3-methylbenzenecarboximidamide
    		Control ≥98.0%
    N'-Hydroxy-3-methylbenzenecarboximidamide is an intermediate useful for pharmaceutical synthesis.
    N'-Hydroxy-3-methylbenzenecarboximidamide
  • HY-21315
    Pitavastatin impurity 12
    Pitavastatin impurity 12 is an impurity of Pitavastatin (HY-B0144A).
    Pitavastatin impurity 12
  • HY-108416
    5,7-Dihydroxy-4-methylphthalide
    		99.82%
    5,7-Dihydroxy-4-methylphthalide is a key intermediate in the synthesis of Mycophenolic acid and a secondary metabolite of Aspergillus flavus.
    5,7-Dihydroxy-4-methylphthalide
  • HY-33358
    Valproic acid impurity 1
    Valproic acid impurity 1 is an impurity of Valproic acid (HY-10585).
    Valproic acid impurity 1
  • HY-W009681
    1-(2-Methoxyphenyl)piperazine hydrochloride
    		99.59%
    1-(2-Methoxyphenyl)piperazine hydrochloride is a key agent intermediate of antipsychotics with high affinity to the serotonin receptors and 5-HT, which can be used to synthesize the intestinal worm-repellent agents Piperazine phosphate (HY-B0912C) and Piperazine citrate (HY-17599), as well as Fluphenazine (HY-119980), dihydrochloride, Rifampicin (HY-B0272).
    1-(2-Methoxyphenyl)piperazine hydrochloride
  • HY-100079
    9-Propenyladenine
    9-Propenyladenine is a mutagenic impurity in tenofovir disoproxil fumarate. Tenofovir is an antiretroviral agent known as nucleotide analogue reverse transcriptase inhibitors, which block reverse transcriptase, a crucial virus enzyme in HIV-1 and HBV.
    9-Propenyladenine
  • HY-Z0141
    4-Biphenylmethanol
    		99.06%
    4-Biphenylmethanol is a drug impurity.
    4-Biphenylmethanol
  • HY-78496
    Ticagrelor impurity 27
    		99.01%
    Ticagrelor impurity 7 is an impurity of Ticagrelor (HY-10064).
    Ticagrelor impurity 27
  • HY-204565
    4-Methyl-3-hydroxyanthranilic acid
    4-Methyl-3-hydroxyanthranilic acid (MHA) is a key precursor for the synthesis of Actinomycin D (HY-17559).
    4-Methyl-3-hydroxyanthranilic acid
  • HY-W100829
    FPPS ligand 3
    FPPS ligand 3 (compound 2) is a farnesyl pyrophosphate synthase (FPPS) ligand. FPPS ligand 3 binds to the hydrophobic base region of the FPPS pocket. FPPS ligand 3 can be used to design and synthesize FPPS inhibitors.
    FPPS ligand 3